Ronald Goldberg, MD


Endocrinology, Diabetes, Metabolism: University of Chicago Hospital

Internal Medicine: Johannesburg General Hospital

MD: University of Witwatersrand. Johannesburg, South Africa

Undergraduate: University of Witwatersrand. Johannesburg, South Africa


Dr. Ronald B Goldberg is Professor of Medicine, Division of Endocrinology, Diabetes and Metabolism, is a senior faculty member  of the Diabetes Research Institute (DRI), and has a secondary appointment as Professor of Biochemistry and Molecular Biology.

He completed his medical training in Johannesburg, South Africa, emigrating to the United States in 1977 to complete his Endocrine training at the University of Chicago, where he was a SCOR Atherosclerosis Trainee, before taking up a faculty position at the University of Miami Miller School of Medicine. During his tenure he has served as Chief of the Division of Diabetes and Metabolism (1988-1999) and Director of the DRI Kosow Diagnostic and Treatment Center (1986-1999) and was responsible for setting up the DRI Clinical research Laboratory of which he is still Co-Director. He is also a Diplomate of the American Board of Clinical Lipidology.

His research is directed at the prevention oftype 2 diabetes and its complications especially cardiovascular disease, and on lipids and lipoproteins and their clinical importance . He is a Principal Investigator of the NIH funded Diabetes Prevention Program He has been principal Investigator of many studies funded either by industry or jointly with the NIH focused on the pharmacotherapy of diabetes and atherosclerotic disease prevention and management of type 2 diabetes. In addition he brings his expertise in these areas as an investigator to several collaborative NIH funded studies that include a study of stroke, a study of the effect of the built environment on development of the metabolic syndrome in recently arrived Cuban immigrants and an investigation of atherosclerosis risk in children with HIV on long-term antiretroviral therapy. He has a strong interest in undergraduate and postgraduate medical education, and was the Director of the Southeast Florida Diabetes Center Program, a State funded activity devoted mainly to education from 1996-2008. He is the ADA representative on the ACC/AHA committee developing the 2018 Guideline on the Management and Treatment of Cholesterol. He is active in mentoring Fellows in the Division of Endocrinology and medical residents in their research projects and in clinical lipidology and diabetology as Directorof the University of Miami Lipid Disorders Clinic and based on his experience and expertise as a diabetologist.